# Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

> **NCT00898313** · — · RECRUITING · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 4000 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **GENETIC:** comparative genomic hybridization
- **GENETIC:** gene expression microarray analysis
- **GENETIC:** proteomic profiling analysis
- **OTHER:** biologic sample preservation procedure
- **PROCEDURE:** nasal brushing
- **PROCEDURE:** Blood draw
- **PROCEDURE:** Urine collection
- **PROCEDURE:** sputum sample
- **PROCEDURE:** fluorescence bronchoscopy with airway biopsy
- **PROCEDURE:** fine needle aspiration of the lung
- **PROCEDURE:** thoracentesis

## Key facts

- **NCT ID:** NCT00898313
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2003-12
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 4000 (ESTIMATED)
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00898313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00898313, "Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00898313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*